Stay updated on Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial page.

Latest updates to the Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial page
- Check5 days agoChange DetectedAdded related topics Rheumatoid arthritis and MedlinePlus Genetics to the page's related topics. This does not modify study information or page functionality.SummaryDifference0.0%

- Check12 days agoChange DetectedThe page removed the 'Rheumatoid arthritis' topic tag and the 'MedlinePlus Genetics' related topic. This may affect how the study is discovered and contextualized by disease-related searches and related resources.SummaryDifference0.0%

- Check19 days agoChange DetectedLocations were updated with many new site regions across the US, Canada, Europe, Australia, and other regions, while a substantial number of previously listed locations were removed; the page now displays a revised set of recruitment sites for the study.SummaryDifference3%

- Check26 days agoChange DetectedRheumatoid arthritis is added as a main topic and MedlinePlus Genetics is added to the related topics section, expanding navigational links to genetics resources.SummaryDifference0.0%

- Check34 days agoChange DetectedRemoved from the related topics section: Rheumatoid arthritis and MedlinePlus Genetics. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check48 days agoChange DetectedAdded related topic 'Rheumatoid arthritis' and a MedlinePlus Genetics link. Updated PubMed note to reflect automatic population and revision to v3.3.2; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial page.